article thumbnail

Rising Demand for Pharmaceutical Secondary Packaging Providers

Roots Analysis

This continuously growing pipeline of pharmaceutical drug products has inadvertently led to an increase in the demand for their associated primary packaging and Secondary Packaging solutions. . 3] Some of the advantages offered by pharmaceutical secondary packaging have been depicted below. Company Competitiveness Analysis.

article thumbnail

Syntegon goes live at PACK EXPO Connects 2020

Pharma Mirror

Since the in-person PACK EXPO International and Healthcare Packaging EXPO have been cancelled, the process and packaging technology specialist Syntegon is presenting its latest solutions at the virtually-hosted PACK EXPO Connects from November 9 to 13, 2020.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Exclusive interview with ForwardVue Pharma released for Ophthalmic Drugs 2020

pharmaphorum

What current topic will you be addressing in your presentation, and what would you say makes it relevant to 2020? “We 23 rd -24 th November 2020. For exclusive tailored sponsorship packages contact: Alia Malick on +44 (0)20 7827 6168 or email amalick@smi-online.co.uk. Ophthalmic Drugs Conference. OphthalmicDrugs.

article thumbnail

Pharma contract manufacturing market to grow to $130bn by 2026

European Pharmaceutical Review

The market was valued at approximately $100 billion in 2020. According to the report, the packaging segment of the market will be worth $15.6 billion by 2026, as contract manufacturing organisations increasingly adopt newer and efficient ways to package products, increasing demand for new machinery. billion by 2026.

article thumbnail

Proposed non-animal derived reagent Chapter published

European Pharmaceutical Review

The proposed informational chapter <1085.1> > Use of Recombinant Reagents in the Bacterial Endotoxins Test – Photometric and Fluorometric Methods Using Recombinantly Derived Reagents was published in the Pharmacopeial Forum 46(5) [Sep.-Oct.

article thumbnail

Injectable opportunities for CMOs despite internal capacity of big pharma sponsors

Pharmaceutical Technology

Large (market cap $10–100bn) and mega-cap (market cap >$100bn) sponsors also require contract manufacturers and packagers with specialist injectable capabilities in the case of cell and gene therapies, as shown in the report titled Contract Injectable Packaging Trends in the Bio/Pharma Industry (August 2022).

article thumbnail

Common pharma compliance concerns cited by FDA warning letters

European Pharmaceutical Review

A study of the causes of warning letters issued by the US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) and Center for Devices and Radiological Health (CDRH) between 2010 and 2020 revealed that poor current good manufacturing practice (cGMP) compliance and misbranding were the most common citations.

FDA 94